SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PharmaTher Builds Portfolio of Personalized 3D-Printed Peptide Products

PharmaTher said it is building a portfolio of personalized, 3D-printed peptide products for a new U.S. peptide pathway, led by colon-targeted KPV and BPC-157.

PHRM

Related stories